News

Intellikine has initiated a Phase I clinical trial for its targeted anticancer drug INK128, an orally-available small molecule inhibitor of both the TORC1 and TORC2 complexes, key components

Bioject Medical Technologies (Bioject) has established a strategic alliance with MPI Research. It allows Bioject to gain access to a range of capabilities and resources needed to explore

Insulet and Ypsomed have signed an agreement for the distribution of the OmniPod Insulin Management System in nine countries across Europe, China and Australia. As per the agreement,

The US Patent and Trademark Office (USPTO) has issued a patent to CyDex Pharmaceuticals (CyDex) entitled ‘Sulfoalkyl Ether Cyclodextrin Compositions.’ The patent, along with other previously issued technology

Scientists from Vienna have reportedly developed a new technique for producing vaccines for H1N1, ‘swine flu’, based on insect cells. The research was published in the Biotechnology Journal,

Inverness Medical has entered into a distribution agreement with Epocal of Ottawa, Canada, to distribute its epoc blood analysis system for blood gas and electrolyte testing. The epoc

Formatech has selected the next candidate as ViroMed’s VM206 therapeutic cancer vaccine for its Fillanthropy Program. Under the Fillanthropy Program, Formatech will donate the services required to aseptically

Rexam has reported the closure of its plastic packaging manufacturing plant in Nashua, New Hampshire. The closure is expected to occur in the fourth quarter of 2010. The

LifeVantage has announced that the Protandim, a patented dietary supplement composed of five highly synergistic ‘indirect antioxidants’, is currently the subject of two human clinical trials at the